Back
iShares US Financials ETF Vs. Monopar Therapeutics Industry Stock Comparison
Buy
71
IYF
iShares US Financials ETF
Last Price:
$112.44
Seasonality Move:
3.25%
Sell
45
MNPR
Monopar Therapeutics
Last Price:
$39.96
Seasonality Move:
-24.75%
Buy
71
iShares US Financials ETF (IYF)
is a Buy
Is iShares US Financials ETF a Buy, Sell or Hold?
-
The current iShares US Financials ETF [IYF] share price is $111.28. The Score for IYF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
IYF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $34.37. The Score for MNPR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IYF Stock Price Chart
What is iShares US Financials ETF's stock price today?
-
The iShares US Financials ETF share price today is $111.28Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IYF is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $34.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
IYF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.71 | Sell |
| Relative Strength Index (14 RSI): | 43.7 | Sell |
| Chaikin Money Flow: | -630526 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (111.19 - 118.49) | Sell |
| Bollinger Bands (100): | (110.04 - 117.62) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.8 | Sell |
| Relative Strength Index (14 RSI): | 50.93 | Buy |
| Chaikin Money Flow: | 16181 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.38 - 44.94) | Sell |
| Bollinger Bands (100): | (16.76 - 38.26) | Buy |
IYF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.17 | Buy |
| 20-day SMA: | 114.06 | Sell |
| 50-day SMA: | 114.79 | Sell |
| 200-day SMA: | 106.6 | Buy |
| 8-day EMA: | 111.1 | Buy |
| 20-day EMA: | 113 | Sell |
| 50-day EMA: | 114.05 | Sell |
| 200-day EMA: | 107.18 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.92 | Buy |
| 20-day SMA: | 34.11 | Buy |
| 50-day SMA: | 35.31 | Sell |
| 200-day SMA: | 15.6 | Buy |
| 8-day EMA: | 32.1 | Buy |
| 20-day EMA: | 33.86 | Buy |
| 50-day EMA: | 33.39 | Buy |
| 200-day EMA: | 20.23 | Buy |
iShares US Financials ETF Earnings Growth & IYF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
iShares US Financials ETF Technical Analysis
| Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||